Clinical Trials
3 trialsNCT02289209 2025-03-06
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
University of Pittsburgh
Phase 2 Completed
NCT03854838 2022-04-29
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Sun Yat-sen University
Phase 2 Unknown
NCT03981068 2020-09-25
DAHANCA 37. Re-irradiation With Proton Radiotherapy
Danish Head and Neck Cancer Group
Phase NA Unknown